Vasundhara Rasayans (BSE 538634)₹136.60−2.36%Pharmaceuticals
In the Mar 2026 quarter (standalone), Vasundhara Rasayans reported sales of ₹11.91 Cr, up 53.1% from Mar 2025, and net profit of ₹2.49 Cr, up 441.3% year on year. For the year to Mar 2026, sales were ₹35.78 Cr and net profit ₹5.80 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.35 | 9.34 | 8.24 | 11.16 | 7.65 | 9.80 | 8.84 | 7.78 | 7.57 | 8.85 | 7.46 | 11.91 |
| Expenses | 7.34 | 7.60 | 6.76 | 8.84 | 6.75 | 8.14 | 7.23 | 7.72 | 7.21 | 6.69 | 6.92 | 9.03 |
| Operating Profit | 0.98 | 1.71 | 1.47 | 2.28 | 0.87 | 1.63 | 1.58 | 0.02 | 0.34 | 2.13 | 0.52 | 2.85 |
| OPM % | 11.6% | 18.2% | 17.7% | 20.4% | 11.3% | 16.5% | 17.8% | 0.1% | 4.4% | 24.0% | 6.8% | 23.9% |
| Other Income | 0.43 | 0.28 | 0.51 | 0.75 | 0.46 | 0.54 | 0.55 | 0.84 | 0.69 | 0.87 | 0.68 | 0.70 |
| Interest | 0.07 | 0.04 | 0.02 | 0.08 | 0.07 | 0.09 | 0.07 | 0.09 | 0.15 | 0.10 | 0.11 | 0.09 |
| Depreciation | 0.05 | 0.07 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.11 | 0.12 | 0.12 | 0.12 |
| Profit before tax | 1.30 | 1.89 | 1.88 | 2.87 | 1.18 | 1.99 | 1.97 | 0.67 | 0.78 | 2.79 | 0.98 | 3.35 |
| Tax % | 26.4% | 26.1% | 26.2% | 25.6% | 25.7% | 26.3% | 26.0% | 31.8% | 26.0% | 26.0% | 25.8% | 25.8% |
| Net Profit | 0.97 | 1.40 | 1.39 | 2.14 | 0.87 | 1.48 | 1.46 | 0.46 | 0.58 | 2.07 | 0.73 | 2.49 |
| EPS (Rs) | 3.03 | 4.38 | 4.35 | 6.72 | 2.72 | 4.64 | 4.58 | 1.43 | 1.80 | 6.50 | 2.28 | 7.82 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.31 | 15.44 | 16.61 | 19.77 | 21.23 | 22.73 | 26.75 | 37.95 | 37.04 | 34.09 | 35.78 | 35.79 |
| Expenses | 13.93 | 13.72 | 14.74 | 18.49 | 18.29 | 19.51 | 24.41 | 32.24 | 30.43 | 29.78 | 29.82 | 29.85 |
| Operating Profit | 1.31 | 1.66 | 1.81 | 1.17 | 2.85 | 3.12 | 2.22 | 5.57 | 6.45 | 4.12 | 5.85 | 5.84 |
| OPM % | 8.5% | 10.7% | 10.8% | 5.9% | 13.4% | 13.7% | 8.2% | 14.7% | 17.4% | 12.1% | 16.3% | 16.3% |
| Other Income | 0.26 | 0.45 | 7.77 | 1.05 | 1.16 | 1.00 | 1.05 | 2.31 | 1.95 | 2.36 | 2.91 | 2.94 |
| Interest | 0.58 | 0.40 | 0.18 | 0.09 | 0.07 | 0.10 | 0.10 | 0.26 | 0.22 | 0.35 | 0.46 | 0.45 |
| Depreciation | 0.57 | 0.57 | 0.33 | 0.06 | 0.04 | 0.06 | 0.13 | 0.14 | 0.27 | 0.37 | 0.44 | 0.47 |
| Profit before tax | 0.43 | 1.15 | 9.06 | 2.08 | 3.91 | 3.97 | 3.05 | 7.50 | 7.91 | 5.77 | 7.87 | 7.90 |
| Tax % | 45.3% | 59.7% | 28.1% | 30.0% | 23.7% | 25.8% | 28.7% | 25.3% | 25.9% | 26.4% | 26.5% | — |
| Exceptional items | 0.00 | 0.02 | 4.82 | 0.00 | 0.07 | 0.00 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.25 | 0.47 | 6.53 | 1.46 | 3.00 | 2.95 | 2.18 | 5.60 | 5.87 | 4.26 | 5.80 | 5.87 |
| EPS (Rs) | 0.77 | 1.46 | 20.57 | 4.58 | 9.43 | 9.28 | 6.85 | 17.65 | 18.49 | 13.40 | 18.27 | 18.40 |
| Dividend payout % | 0.0% | 69.1% | 4.9% | 21.9% | 15.9% | 16.2% | 14.6% | 0.0% | 0.0% | 15.0% | 11.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.17 | 3.19 | 3.18 | 3.17 | 3.19 | 3.17 | 3.18 | 3.18 | 3.19 | 3.18 | 3.18 | 3.17 |
| Reserves | 3.71 | 3.94 | 4.03 | 10.52 | 11.59 | 14.17 | 16.69 | 18.33 | 23.59 | 28.71 | 32.32 | 37.62 |
| Borrowings | 5.60 | 5.03 | 3.11 | 1.42 | 0.47 | 0.00 | 0.00 | 1.32 | 4.04 | 1.96 | 4.23 | 1.82 |
| Other Liabilities | 4.15 | 3.19 | 3.14 | 5.25 | 5.57 | 7.32 | 3.15 | 2.67 | 3.70 | 3.42 | 3.31 | 5.22 |
| Total Liabilities | 16.63 | 15.35 | 13.46 | 20.36 | 20.82 | 24.66 | 23.02 | 25.50 | 34.52 | 37.27 | 43.04 | 47.83 |
| Fixed Assets | 7.63 | 7.29 | 6.79 | 0.11 | 0.21 | 0.31 | 0.68 | 0.92 | 0.87 | 2.44 | 2.50 | 2.36 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.22 | 0.17 | 0.08 | 1.09 | 1.22 | 0.96 | 1.13 | 0.33 | 0.00 | 1.15 | 2.36 | 2.50 |
| Other Assets | 8.78 | 7.89 | 6.59 | 19.16 | 19.39 | 23.39 | 21.21 | 24.25 | 33.65 | 33.68 | 38.18 | 42.97 |
| Inventories | 1.31 | 1.15 | 1.29 | 1.27 | 1.56 | 1.51 | 1.42 | 2.22 | 4.01 | 1.74 | 1.89 | 1.53 |
| Trade receivables | 3.77 | 3.92 | 3.79 | 6.00 | 5.13 | 6.25 | 6.19 | 7.37 | 8.08 | 6.24 | 4.16 | 7.49 |
| Cash & equivalents | 0.15 | 0.13 | 0.38 | 0.71 | 0.30 | 0.80 | 0.68 | 10.73 | 7.71 | 9.53 | 5.52 | 2.52 |
| Total Assets | 16.63 | 15.35 | 13.46 | 20.36 | 20.82 | 24.66 | 23.02 | 25.50 | 34.52 | 37.27 | 43.04 | 47.83 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.57 | 1.33 | 2.43 | −10.71 | 0.44 | 0.37 | 0.23 | 7.91 | −6.51 | 6.04 | −5.84 | −1.59 |
| Cash from investing activity | −2.01 | −0.05 | 0.06 | 13.29 | 0.54 | 1.03 | 0.15 | 1.38 | 1.26 | −1.31 | 0.45 | 2.00 |
| Cash from financing activity | 0.45 | −1.27 | −2.23 | −2.25 | −1.35 | −0.86 | −0.48 | 0.78 | 2.18 | −2.87 | 1.34 | −3.43 |
| Net cash flow | 0.00 | −0.02 | 0.25 | 0.34 | −0.42 | 0.51 | −0.13 | 10.09 | −3.05 | 1.84 | −4.03 | −3.02 |
| Capex | 2.05 | 0.21 | 0.06 | 0.00 | 0.13 | 0.12 | 0.41 | 0.34 | 0.07 | 1.82 | 0.41 | 0.29 |
| Free cash flow | −0.51 | 1.11 | 2.39 | 3.35 | 0.30 | 0.24 | −0.21 | 7.56 | −6.59 | 4.21 | −6.26 | −1.89 |
| CFO / OP % | 117.0% | 114.1% | 164.0% | −457.0% | 153.1% | 36.0% | 51.0% | 397.1% | −95.0% | 125.0% | −78.0% | −13.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 73 | 92 | 89 | 131 | 94 | 106 | 98 | 99 | 77 | 60 | 44 | 75 |
| Inventory days | 47 | 55 | 70 | 65 | 62 | 60 | 49 | 59 | 80 | 40 | 45 | 38 |
| Days payable | 59 | 31 | 52 | 61 | 44 | 58 | 76 | 57 | 48 | 39 | 42 | 67 |
| Cash conversion cycle | 60 | 115 | 106 | 134 | 110 | 107 | 71 | 101 | 108 | 60 | 46 | 45 |
| Working capital days | 13 | 13 | 16 | 260 | 247 | 268 | 145 | 129 | 176 | 195 | 275 | 345 |
| ROCE % | 12.0% | 8.1% | 13.4% | 14.2% | 14.1% | 23.7% | 21.7% | 12.9% | 28.8% | 25.0% | 16.6% | 20.2% |
For the Mar 2026 quarter, Vasundhara Rasayans reported sales of ₹11.91 Cr, up 53.1% year on year and net profit of ₹2.49 Cr, up 441.3% year on year. The operating margin was 23.9%.
Vasundhara Rasayans' sales for the year to Mar 2026 were ₹35.78 Cr; over the last twelve months they were ₹35.79 Cr.
Net profit for the year to Mar 2026 was ₹5.80 Cr, and ₹5.87 Cr over the last twelve months. Earnings per share over the same trailing period were ₹18.40.
Vasundhara Rasayans reported borrowings of ₹1.82 Cr at Mar 2026, against cash and equivalents of ₹2.52 Cr.
Cash from operations was −₹1.59 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.89 Cr.